Nuclear medicine therapy increases survival for patients with colorectal cancer, liver metastases
Thursday, November 7, 2013 - 12:30
in Health & Medicine
For patients who fail to respond to current first-line and second-line treatments for colorectal cancer liver metastases, radioembolization with Y-90 microspheres could extend survival according to new research. A systematic review showed that approximately 50 percent of salvage patients have an overall survival of more than 12 months after this nuclear medicine therapy.